ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Two Private Cancer Information Services Are Up and Running

May 13, 1988

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003